Closing the Information Gap on International Surrogacy
By Elayne Clift,
Women's Media Center
| 07. 16. 2014
[Quotes CGS's Marcy Darnovsky]
Untitled Document
Beth G. had eight miscarriages before she and her partner considered in vitro fertilization (IVF). The couple also discussed adoption, but they ultimately opted for a surrogate in India. Beth and her partner visited Mumbai before signing on and felt that the gestational mothers in their agency were well cared for and decently compensated. But what did they really know about the practice of cross-border surrogacy?
In order to help close the information gap that exists around both cross-border surrogacy and commercial egg retrieval (from egg “donors”), the MacArthur Foundation recently awarded the women’s health advocacy group Our Bodies Ourselves (OBOS) and the Center for Genetics and Society (CGS) a two-year, $200,000 grant to support the collaborating organizations’ joint efforts to bring a human rights and social justice perspective to these two assisted reproductive technologies (ART) and to the rapidly growing industry they have spawned. Most countries prohibit commercial surrogacy, but in nations where it is allowed, policies vary greatly. India is the most popular destination, but prospective parents seek paid surrogates in a number of countries, including...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...